PureTech Health plc (LON:PRTC)
London · Delayed Price · Currency is GBP · Price in GBX 115.00
-1.00 (-0.86%)
Sep 25, 2026, 12:05 PM GMT
PureTech Health Market Cap
PureTech Health has a market cap or net worth of 284.41 million as of September 24, 2026. Its market cap has decreased by -7.19% in one year.
Market Cap
284.41M
Enterprise Value
272.70M
Revenue
4.80M
Ranking
n/a
PE Ratio
197.22
Stock Price
115.00
ChartMarket Cap Chart
Since June 19, 2015, PureTech Health's market cap has decreased from 404.50M to 284.41M, a decrease of -29.69%. That is a compound annual growth rate of -3.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 284.41M | -5.86% |
| Dec 31, 2025 | 302.11M | -15.99% |
| Dec 31, 2024 | 359.61M | -31.88% |
| Dec 29, 2023 | 527.94M | -28.89% |
| Dec 30, 2022 | 742.38M | -11.66% |
| Dec 31, 2021 | 840.37M | -26.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oxford Nanopore Technologies | 1.69B |
| Genus | 1.39B |
| Oxford Biomedica | 593.09M |
| Avacta Group | 346.62M |
| Scancell Holdings | 116.37M |
| 4basebio | 87.40M |
| Bioventix | 80.99M |
| Faron Pharmaceuticals Oy | 73.32M |